Advertisement
Screener

Ionis Pharmaceuticals, Inc. (IONS) Gain (Loss) on Investments

2.2 / 5 stars · 52/118 Roast Me

Ionis Pharmaceuticals, Inc. Gain (Loss) on Investments

Ionis Pharmaceuticals, Inc. (IONS) reported Gain (Loss) on Investments of -$10.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Income Statement › Other Income

us-gaap:GainLossOnInvestments · last filed 2026-07-29

  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for the quarter ending 2026-06-30 was -$10.18M.
  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for the quarter ending 2026-03-31 was $22.58M.
  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for the quarter ending 2025-12-31 was $788.00K.
  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for the quarter ending 2025-09-30 was $29.91M, a 3302.50% increase year-over-year.
  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for fiscal 2025 was $10.22M.
  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for fiscal 2024 was -$2.89M.
  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for fiscal 2023 was -$1.91M.
  • Ionis Pharmaceuticals, Inc. gain (loss) on investments for fiscal 2022 was -$7.33M, a 172.58% decline from fiscal 2021.
Period endGain (Loss) on Investments 3 monthGain (Loss) on Investments 3 month as first filedGain (Loss) on Investments 6 monthGain (Loss) on Investments 9 monthGain (Loss) on Investments 12 month
2026-06-30-$10.18M
10-Q · filed 2026-07-29
$12.40M
10-Q · filed 2026-07-29
$13.19M
derived: sum of 3 quarters · filed 2026-07-29
$43.10M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$22.58M
10-Q · filed 2026-04-29
$23.37M
derived: sum of 2 quarters · filed 2026-04-29
$53.28M
derived: sum of 3 quarters · filed 2026-04-29
$34.97M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$788.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$30.70M
derived: sum of 2 quarters · filed 2026-02-26
$12.38M
derived: sum of 3 quarters · filed 2026-07-29
$10.22M
10-K · filed 2026-02-26
2025-09-30$29.91M
10-Q · filed 2025-10-29
$11.60M
derived: sum of 2 quarters · filed 2026-07-29
$9.43M
10-Q · filed 2025-10-29
$6.86M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30-$18.31M
10-Q · filed 2026-07-29
-$20.48M
10-Q · filed 2026-07-29
-$23.04M
derived: sum of 3 quarters · filed 2026-07-29
-$22.16M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31-$2.16M
10-Q · filed 2026-04-29
-$4.73M
derived: sum of 2 quarters · filed 2026-04-29
-$3.85M
derived: sum of 3 quarters · filed 2026-04-29
-$7.39M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31-$2.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$1.69M
derived: sum of 2 quarters · filed 2026-02-26
-$5.22M
derived: sum of 3 quarters · filed 2026-02-26
-$2.89M
10-K · filed 2026-02-26
2024-09-30$879.00K
10-Q · filed 2025-10-29
-$2.65M
derived: sum of 2 quarters · filed 2025-10-29
-$321.00K
10-Q · filed 2025-10-29
-$482.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30-$3.53M
10-Q · filed 2025-07-30
-$1.20M
10-Q · filed 2025-07-30
-$1.36M
derived: sum of 3 quarters · filed 2026-02-26
-$3.30M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$2.33M
10-Q · filed 2025-04-30
$2.17M
derived: sum of 2 quarters · filed 2026-02-26
$229.00K
derived: sum of 3 quarters · filed 2026-02-26
$947.00K
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31-$161.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$2.10M
derived: sum of 2 quarters · filed 2026-02-26
-$1.39M
derived: sum of 3 quarters · filed 2026-02-26
-$1.91M
10-K · filed 2026-02-26
2023-09-30-$1.94M
10-Q · filed 2024-11-06
-$1.23M
derived: sum of 2 quarters · filed 2024-11-06
-$1.75M
10-Q · filed 2024-11-06
$1.53M
derived: sum of 4 quarters · filed 2025-02-19
2023-06-30$718.00K
10-Q · filed 2024-08-01
$189.00K
10-Q · filed 2024-08-01
$3.47M
derived: sum of 3 quarters · filed 2025-02-19
$5.82M
derived: sum of 4 quarters · filed 2025-02-19
2023-03-31-$529.00K
10-Q · filed 2024-05-07
$2.75M
derived: sum of 2 quarters · filed 2025-02-19
$5.10M
derived: sum of 3 quarters · filed 2025-02-19
-$1.24M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$3.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$5.63M
derived: sum of 2 quarters · filed 2025-02-19
-$707.00K
derived: sum of 3 quarters · filed 2025-02-19
-$7.33M
10-K · filed 2025-02-19
2022-09-30$2.35M
10-Q · filed 2023-11-02
-$3.99M
derived: sum of 2 quarters · filed 2023-11-02
-$10.62M
10-Q · filed 2023-11-02
-$5.40M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30-$6.34M
10-Q · filed 2023-08-09
-$12.96M
10-Q · filed 2023-08-09
-$7.74M
derived: sum of 3 quarters · filed 2024-02-21
-$3.73M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31-$6.63M
10-Q · filed 2023-05-03
-$1.41M
derived: sum of 2 quarters · filed 2024-02-21
$2.61M
derived: sum of 3 quarters · filed 2024-02-21
$3.47M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$5.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$9.23M
derived: sum of 2 quarters · filed 2024-02-21
$10.09M
derived: sum of 3 quarters · filed 2024-02-21
$10.10M
10-K · filed 2024-02-21
2021-09-30$4.01M
10-Q · filed 2022-11-09
$4.87M
derived: sum of 2 quarters · filed 2022-11-09
$4.88M
10-Q · filed 2022-11-09
$10.69M
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$860.00K
10-Q · filed 2022-08-09
$873.00K
10-Q · filed 2022-08-09
$6.68M
derived: sum of 3 quarters · filed 2023-02-22
$7.51M
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$0.00
10-Q · filed 2022-05-04
$13.00K
10-Q · filed 2021-05-05
$5.82M
derived: sum of 2 quarters · filed 2023-02-22
$6.65M
derived: sum of 3 quarters · filed 2023-02-22
$16.28M
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$5.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$6.65M
derived: sum of 2 quarters · filed 2023-02-22
$16.28M
derived: sum of 3 quarters · filed 2023-02-22
$16.54M
10-K · filed 2023-02-22
2020-09-30$835.00K
10-Q · filed 2021-11-03
$10.46M
derived: sum of 2 quarters · filed 2021-11-03
$10.72M
10-Q · filed 2021-11-03
$10.90M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$9.63M
10-Q · filed 2021-08-04
$9.89M
10-Q · filed 2021-08-04
$10.06M
derived: sum of 3 quarters · filed 2022-02-25
$10.06M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$246.00K
10-Q · filed 2021-05-05
$438.00K
derived: sum of 2 quarters · filed 2022-02-25
$438.00K
derived: sum of 3 quarters · filed 2022-02-25
$438.00K
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$192.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$192.00K
derived: sum of 2 quarters · filed 2022-02-25
$192.00K
derived: sum of 3 quarters · filed 2022-02-25
$192.00K
10-K · filed 2022-02-25
2019-09-30$0.00
10-Q · filed 2020-11-04
$0.00
derived: sum of 2 quarters · filed 2020-11-04
$0.00
10-Q · filed 2020-11-04
2019-06-30$0.00
10-Q · filed 2020-08-05
$0.00
10-Q · filed 2020-08-05
2018-12-31-$210.00K
10-K · filed 2021-02-24
2015-06-30$1.00K
10-Q · filed 2015-08-05
$1.00K
10-Q · filed 2015-08-05
$582.00K
derived: sum of 3 quarters · filed 2015-08-05
$1.12M
derived: sum of 4 quarters · filed 2015-08-05
2015-03-31$0.00
10-Q · filed 2015-05-05
$581.00K
derived: sum of 2 quarters · filed 2015-05-05
$1.12M
derived: sum of 3 quarters · filed 2015-05-05
$859.00K
derived: sum of 4 quarters · filed 2015-08-05
2014-12-31$581.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$1.12M
derived: sum of 2 quarters · filed 2015-03-02
$859.00K
derived: sum of 3 quarters · filed 2015-08-05
$1.26M
10-K · filed 2015-03-02
2014-09-30$538.00K
10-Q · filed 2014-11-07
$278.00K
derived: sum of 2 quarters · filed 2015-08-05
$675.00K
10-Q · filed 2014-11-07
$980.00K
derived: sum of 4 quarters · filed 2015-08-05
2014-06-30-$260.00K
10-Q · filed 2015-08-05
$137.00K
10-Q · filed 2015-08-05
$442.00K
derived: sum of 3 quarters · filed 2015-08-05
$617.00K
derived: sum of 4 quarters · filed 2015-08-05
2014-03-31$397.00K
10-Q · filed 2015-05-05
$702.00K
derived: sum of 2 quarters · filed 2015-05-05
$877.00K
derived: sum of 3 quarters · filed 2015-05-05
$1.72M
derived: sum of 4 quarters · filed 2015-05-05
2013-12-31$305.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$480.00K
derived: sum of 2 quarters · filed 2015-03-02
$1.32M
derived: sum of 3 quarters · filed 2015-03-02
$2.38M
10-K · filed 2015-03-02
2013-09-30$175.00K
10-Q · filed 2014-11-07
$1.01M
derived: sum of 2 quarters · filed 2014-11-07
$2.07M
10-Q · filed 2014-11-07
$3.52M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$840.00K
10-Q · filed 2014-08-04
$1.90M
10-Q · filed 2014-08-04
$3.34M
derived: sum of 3 quarters · filed 2015-03-02
$3.34M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$1.06M
10-Q · filed 2014-05-06
$2.50M
derived: sum of 2 quarters · filed 2015-03-02
$2.50M
derived: sum of 3 quarters · filed 2015-03-02
$2.51M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$1.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$1.45M
derived: sum of 2 quarters · filed 2015-03-02
$1.45M
derived: sum of 3 quarters · filed 2015-03-02
$1.47M
10-K · filed 2015-03-02
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
$2.00K
derived: sum of 2 quarters · filed 2013-11-05
$19.00K
10-Q · filed 2013-11-05
$4.47M
derived: sum of 4 quarters · filed 2014-03-03
2012-06-30$2.00K
10-Q · filed 2013-08-06
$19.00K
10-Q · filed 2013-08-06
$4.47M
derived: sum of 3 quarters · filed 2014-03-03
$4.49M
derived: sum of 4 quarters · filed 2014-03-03
2012-03-31$17.00K
10-Q · filed 2013-05-07
$4.47M
derived: sum of 2 quarters · filed 2014-03-03
$4.48M
derived: sum of 3 quarters · filed 2014-03-03
$4.52M
derived: sum of 4 quarters · filed 2014-03-03
2011-12-31$4.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03
$4.47M
derived: sum of 2 quarters · filed 2014-03-03
$4.50M
derived: sum of 3 quarters · filed 2014-03-03
$4.18M
10-K · filed 2014-03-03
2011-09-30$18.00K
10-Q · filed 2012-11-06
$52.00K
derived: sum of 2 quarters · filed 2012-11-06
-$267.00K
10-Q · filed 2012-11-06
$183.00K
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$34.00K
10-Q · filed 2012-08-06
-$285.00K
10-Q · filed 2012-08-06
$165.00K
derived: sum of 3 quarters · filed 2013-02-28
$150.00K
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31-$318.00K
10-Q · filed 2012-05-09
$131.00K
derived: sum of 2 quarters · filed 2013-02-28
$116.00K
derived: sum of 3 quarters · filed 2013-02-28
-$20.00K
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$449.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$434.00K
derived: sum of 2 quarters · filed 2013-02-28
$298.00K
derived: sum of 3 quarters · filed 2013-02-28
-$713.00K
10-K · filed 2013-02-28
2010-09-30-$15.00K
10-Q · filed 2011-11-08
-$151.00K
derived: sum of 2 quarters · filed 2011-11-08
-$1.16M
10-Q · filed 2011-11-08
-$1.87M
derived: sum of 4 quarters · filed 2012-02-29
2010-06-30-$136.00K
10-Q · filed 2011-08-08
-$1.15M
10-Q · filed 2011-08-08
-$1.86M
derived: sum of 3 quarters · filed 2012-02-29
-$1.73M
derived: sum of 4 quarters · filed 2012-02-29
2010-03-31-$1.01M
10-Q · filed 2011-05-06
-$1.72M
derived: sum of 2 quarters · filed 2012-02-29
-$1.60M
derived: sum of 3 quarters · filed 2012-02-29
$1.01M
derived: sum of 4 quarters · filed 2012-02-29
2009-12-31-$710.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29
-$587.00K
derived: sum of 2 quarters · filed 2012-02-29
$2.02M
derived: sum of 3 quarters · filed 2012-02-29
$2.08M
10-K · filed 2012-02-29
2009-09-30$123.00K
10-Q · filed 2010-11-05
$2.73M
derived: sum of 2 quarters · filed 2010-11-05
$2.79M
10-Q · filed 2010-11-05
2009-06-30$2.61M
10-Q · filed 2010-08-09
$2.67M
10-Q · filed 2010-08-09
2008-12-31-$965.00K
10-K · filed 2011-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Alkermes plc. (ALKS)$6.844B132.74
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10